(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 19.15% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Progyny's revenue in 2024 is $1,088,598,000.On average, 5 Wall Street analysts forecast PGNY's revenue for 2024 to be $125,404,060,880, with the lowest PGNY revenue forecast at $124,894,351,039, and the highest PGNY revenue forecast at $126,423,866,560. On average, 5 Wall Street analysts forecast PGNY's revenue for 2025 to be $150,309,784,541, with the lowest PGNY revenue forecast at $147,692,334,761, and the highest PGNY revenue forecast at $153,520,898,642.
In 2026, PGNY is forecast to generate $178,333,982,877 in revenue, with the lowest revenue forecast at $171,523,827,079 and the highest revenue forecast at $184,912,154,112.